|
|
|
A premium listing of acknowledged professionals in the Information Technology World
|
|
Featured are a selection of Information Technology professionals who have gained expertise over a specific area of technology. These professionals have gained years of valuable experience making them acknowledged gurus in their respective area of technology and have to their credit a long list of publications and presentations that share their knowledge with the global developer community.
|
|
|
ALL
@
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
|
|
|
|
George Anders
|
|
Editor, Wall Street Journal |
|
George Anders is a news editor at The Wall Street Journal, specializing in front-page profiles. In recent months he has writte n about topics that include Paul Allen?s investment strategies, Broadcom?s leadership turmoil and the efforts to revive a Neva da ghost town. He was part of a team of WSJ reporters that shared the Pulitzer Prize for national reporting in 1997. Mr. Ander s also has written three books. The most recent book, on Hewlett-Packard, was a New York Times bestseller. He is a graduate of Stanford University and is based in Silicon Valley.
|
|
|
John Byrne
|
|
Editor-in-Chief , Fast Company magazine |
|
John Byrne is the editor-in-chief of Fast Company magazine and the author of eight books on business, leadership and managemen t. He joined Fast Company in April of 2003, succeeding founding editors Alan Webber and Bill Taylor. He is working to reinvent the nine-year-old business magazine, which has a circulation of 730,000 and a readership of more than 2.5 million. Before his current position, Byrne was a senior writer at Business Week in New York and the author of 57 cover stories at the magazine. He has written on an exceptionally broad range of topics and companies, from leadership and management to strategy and culture , from IBM and Cisco to Philip Morris and Merck. Byrne also is the creator of Business Week?s ranking of the best business sch ools (which was launched in 1988), the best and worst boards of directors in America (which first appeared in 1996), and its l isting of the nation?s most generous philanthropists (which first appeared in 2002). He is a frequent commentator on televisio n, having appeared on CNN?s Moneyline and CNBC?s Squawk Box and Business Center shows, and a frequent public speaker on such t opics as creativity and innovation to leadership and corporate governance.
|
|
|
Bruce Chizen
|
|
Chief Executive Officer, Adobe Systems Incorporated |
Bruce Chizen is the CEO of Adobe Systems. Chizen~s customer-focused vision is transforming Adobe from a desktop software busin ess to a technology platform provider for consumers, creative professionals, and enterprises. Chizen also has maintained the c ompany~s legendary employee culture. In 2005, Adobe was named for the sixth year to Fortune Magazine~s annual list of the ?100 Best Companies to Work For.? Prior to becoming CEO in December 2000, Chizen was executive vice president of worldwide product s and marketing. In that role, he closely aligned marketing functions and product development to build customer-focused soluti ons.
Chizen started his career in the consumer electronics business during the first wave of growth in the video game mark et. He worked in Mattel Electronics~ merchandising group, helping grow it to a $500 million business. Prior to joining Adobe, he held senior positions at Microsoft Corporation and Claris Corporation. Chizen holds a bachelor~s degree from Brooklyn Colle ge, City University of New York. He serves on the board of Synopsys, Inc. and is president of the board of directors for the Children~s Discovery Museum of San Jose.
|
|
|
Fred Frank
|
|
Vice Chair and Director, Lehman Brothers |
Mr. Frank is vice chair and director of Lehman Brothers. 'He is generally referred to as the dean of the investment bankers wo rking the biotechnology sector,' says G. Steven Burrill, a merchant banker in the biotech industry. And no wonder. Mr. Frank h as engineered--and reengineered--the complex financial architecture of biotech, overseeing seminal deals like the Genentech an d Hoffmann-La Roche Holdings merger. Among the other high-profile notches on his belt: Mr. Frank took public Applied Biosystem s, the first gene-sequencing machine manufacturer {now owned by Perkin-Elmer}. And in 1993, he worked with Craig Venter and Wi lliam Haseltine in a $125 million collaboration between Human Genome Sciences and SmithKline Beecham. At the time, this was th e largest biotech alliance in history.
Before joining Lehman Brothers as a Partner in October, 1969, Mr. Frank was co-direc tor of research, as well as Vice President and Director, of Smith, Barney & Co. Incorporated. He is a Chartered Financial Anal yst, a member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts.
Born in Salt Lake City on May 31, 1932, Mr. Frank graduated from the Hotchkiss School in 1950 and from Yale University in 1 954. He then spent two years in the Army, most of the time stationed with Supreme Headquarters Allied Powers Europe (SHAPE) in Paris. After release from service, he attended Stanford Graduate School of Business Administration. He received his MBA from Stanford in 1958 and began his Wall Street career that year.
In addition to serving as a director of Business Engine, Diag nostic Products Corporation, Digital Arts & Sciences, Inc., eSoft, Incorporated, Landec Corporation, Pharmaceutical Product De velopment, Inc., and Physiome Sciences, he is Chairman of the National Genetics Foundation, a director of the Salk Institute, Trustee Emeritus of The Hotchkiss School, a member of the Yale School of Organization and Management Advisory Board, a member of the Pharmaceutical Executive Magazine advisory board, a member of the Board of Governors of the National Center for Genome Resources and Chairman of the Board of The Irvington Institute for Immunological Research.
|
|
|
|
Mr. Bruce Jennett
|
|
Jennett, Heller Ehrman |
Mr. Jenett practices corporate law and is Co-Leader of the firm?s Life Sciences Practice.
Mr. Jenett~s practice is focused on the representation of domestic and international high technology business clients, primarily in the life sciences industry. He is highly experienced in equity and debt financing, licensing and distribution, strategic alliances, joint ventures, and m ergers and acquisitions, as well as general counseling issues, representing both start-ups and large multinational corporation s. Mr. Jenett has represented such clients as Bayer Corporation and Bayer AG, BIO (the Biotechnology Industry Organization), C ardioGenesis Corporation, Calypte Biomedical Corporation, Indigo Medical, Inc., Gryphon Therapeutics, Hitachi Chemical Diagnos tics, Entelos, Inc., Nautilus Biotech S.A., Pelikan Technologies, Inc., Thoratec Corporation, TransMolecular, Inc., VisionCare Ophthalmic Technologies, Inc., Astellas (Yamanouchi) Venture Capital LLC, and numerous life sciences and telecommunications s tart-up incubators.
Mr. Jenett is a frequent speaker on corporate and finance issues to both business and attorney audienc es. Mr. Jenett is a member of the Bioethics Committee of BIO, of the Advisory Board of the journal Silicon Valley Business Ink , of the BayBio Board of Directors, and of San Francisco Mayor Gavin Newsom?s Biotech Advisory Council.
Mr. Jenett also is named by Chambers & Partners as one of America~s leading business lawyers
EDUCATION: Princeton University (B.A., Sociology, 1969); Georgetown University Law Center (J.D., 1976).
|
|
|
|
|
Top
|
|
|
|
|
|
|
|
|
|
|
|
|
|
